A degradome-based prognostic signature that correlates with immune infiltration and tumor mutation burden in breast cancer.

Yulou Luo,Yinghui Ye,Yan Chen,Chenguang Zhang,Yutian Sun,Chengwei Wang,Jianghua Ou

Frontiers in immunology（2023）

引用 0|浏览10

暂无评分

摘要

Multidimensional evaluation verified the clinical utility of the degradome signature in predicting prognosis, risk stratification and guiding treatment for patients with breast cancer.

查看译文

关键词

breast cancer,degradome,immune infiltration,immunotherapy,prognostic signature,tumour mutation burden

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要